Viskase Holdings, Inc. (VISK)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $42k
- Aug 13 · Plan not stated
- Form 4 sales
- 24
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 salePlan not statedMar 15, 2012 2012
Sold 2,000 shares at $6.92 ($14k)
Young Richard A, Director
Sold 9.3% of holdings ($149k position)19,562 shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualJun 5, 2012 +82 days
Sold 25,000 shares at $6.78 ($170k)
Conover Charles, SVP, R&D Program Management
Sold 30.4% of holdings ($557k position)57,213 shares leftFirst sale on recordFiling
- 3 Form 4 salePlan not statedJun 5, 2012 same day
Sold 1,614 shares at $6.81 ($11k)
Rackear Andrew D., VP and General Counsel
Sold 2.8% of holdings ($397k position)56,720 shares leftFiling
- 4 Form 4 salePlan not statedAug 10, 2012 +66 days
Sold 1,933 shares at $6.58 ($13k)
Lebuhn Robert, Director
Sold 1.8% of holdings ($697k position)103,935 shares left0.2x usual sizeFiling
- 5 Form 4 salePlan not statedAug 14, 2012 +4 days
Sold 5,820 shares at $6.58 ($38k)
Lebuhn Robert, Director
Sold 5.6% of holdings ($684k position)98,115 shares left0.6x usual sizeFiling
- 6 Form 4 saleUnusualSep 19, 2013 +401 days
Sold 55,926 shares at $1.72 ($96k)
Lebuhn Robert, Director
Sold 57% of holdings ($169k position)42,189 shares leftFiling
- 7 Form 4 salePlan not statedAug 25, 2020 +2532 days
Sold 77,100 shares at $0.18 ($14k)
Couchman Jonathan, 10% owner
Sold 4.6% of holdings ($306k position)1.6M shares leftFirst sale on recordFiling
- 8 Form 4 salePlan not statedAug 13, 2021 +353 days
Sold 107,500 shares at $0.39 ($42k)
Xstelos Corp., 10% owner
Sold 5% of holdings ($839k position)2M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (24)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Aug 17, 2021 | Xstelos Corp. | 10% owner | Form 4 sale | 107,500 | $42k | 5.0% | Plan not stated | SEC |
| Aug 25, 2020 | Aug 26, 2020 | Couchman Jonathan | 10% owner | Form 4 sale | 77,100 | $14k | 4.6% | Plan not stated | SEC |
| Sep 19, 2013 | Sep 19, 2013 | Lebuhn Robert | Director | Form 4 sale | 55,926 | $96k | 57.0% | Unusual | SEC |
| Aug 14, 2012 | Aug 15, 2012 | Lebuhn Robert | Director | Form 4 sale | 5,820 | $38k | 5.6% | Plan not stated | SEC |
| Aug 10, 2012 | Aug 13, 2012 | Lebuhn Robert | Director | Form 4 sale | 1,933 | $13k | 1.8% | Plan not stated | SEC |
| Jun 5, 2012 | Jun 6, 2012 | Rackear Andrew D. | VP and General Counsel | Form 4 sale | 1,614 | $11k | 2.8% | Plan not stated | SEC |
| Jun 5, 2012 | Jun 6, 2012 | Conover Charles | SVP, R&D Program Management | Form 4 sale | 25,000 | $170k | 30.4% | Unusual | SEC |
| Mar 15, 2012 | Mar 16, 2012 | Young Richard A | Director | Form 4 sale | 2,000 | $14k | 9.3% | Plan not stated | SEC |
| Nov 10, 2011 | Nov 10, 2011 | Rackear Andrew D. | VP and General Counsel | Form 4 sale | 3,766 | $25k | 7.2% | Plan not stated | SEC |
| Nov 8, 2011 | Nov 10, 2011 | Buchbinder Aby | VP, Clinical Development | Form 4 sale | 2,700 | $19k | 4.8% | Plan not stated | SEC |
| Jun 1, 2011 | Jun 2, 2011 | Lebuhn Robert | Director | Form 4 sale | 8,702 | $92k | Plan not stated | SEC | |
| Feb 22, 2011 | Feb 24, 2011 | Lebuhn Robert | Director | Form 4 sale | 10,000 | $109k | 9.4% | Plan not stated | SEC |
| Sep 17, 2010 | Sep 17, 2010 | Horak Ivan D | EVP, R&D, CSO | Form 4 sale | 258,900 | $2.8M | 68.3% | Unusual | SEC |
| Aug 26, 2010 | Aug 27, 2010 | Lebuhn Robert | Director | Form 4 sale | 10,000 | $105k | 8.6% | Plan not stated | SEC |
| Jun 18, 2010 | Jun 22, 2010 | Tooman Craig A | Exec VP Finance, CFO | Form 4 sale | 123,100 | $1.4M | 43.4% | Unusual | SEC |
| Feb 24, 2010 | Feb 26, 2010 | Tooman Craig A | Exec. VP Finance, CFO | Form 4 sale | 150,000 | $1.4M | 53.9% | Unusual | SEC |
| Feb 22, 2010 | Feb 24, 2010 | Horak Ivan D | EVP, R&D, CSO | Form 4 sale | 101,329 | $943k | 72.1% | Unusual | SEC |
| Apr 3, 2009 | Apr 7, 2009 | Tooman Craig A | Exec VP Finance, CFO | Form 4 sale | 5,930 | $36k | 4.6% | Plan not stated | SEC |
| Apr 3, 2009 | Apr 7, 2009 | Davit Paul Stephen | Exec. Vice Pres. HR | Form 4 sale | 2,826 | $17k | 4.0% | Plan not stated | SEC |
| Apr 3, 2009 | Apr 7, 2009 | Horak Ivan D | EVP, R&D, Chief Scientific Off | Form 4 sale | 7,035 | $43k | 5.4% | Plan not stated | SEC |
| Jan 17, 2009 | Jan 21, 2009 | Tooman Craig A | Exec VP Finance, CFO | Form 4 sale | 10,306 | $65k | 8.7% | Plan not stated | SEC |
| May 12, 2008 | May 13, 2008 | Renfro Phillip M | Director | Form 4 sale | 15,000 | $142k | 99.8% | Unusual | SEC |
| May 9, 2008 | May 12, 2008 | Renfro Phillip M | Director | Form 4 sale | 5,487 | $52k | 99.6% | Unusual | SEC |
| Dec 11, 2006 | Dec 13, 2006 | Classon Rolf A | Director | Form 4 sale | 30,000 | $247k | 70.6% | Unusual | SEC |